Merck & Co. (MRK)

EBITDA Growth

-77.81%

Quarterly · Period ending:

MRK logo

MRK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-77.81%
MRK Quarterly EBITDA YoY % (23.12% → -77.81%)
High-resolution chart · PNG

MRK ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. EBITDA Growth — Quarterly
Period endingEBITDA Growth
-77.8141%
-127.6418%
10.5707%
46.7356%
-13.7621%
5.1459%
837.6943%
-19.3497%
279.2539%
42.4739%
-116.6379%
45.2361%
-173.3451%
-21.5456%
-6.3194%
-23.067%
114.0159%
52.5864%
661.5646%
67.4112%
-33.7919%
-16.2595%
-122.3517%
8.5597%
-10.4591%
16.6986%
1.1276%
-13.3198%
25.07%
56.5054%
22.0519%
155.93%
-5.9041%
-21.048%
15,323.8095%
-63.5397%
17.6434%
0.6256%
-100.8251%
2.4201%
24.5655%
5.4997%
-81.2163%
25.5164%
-32.4374%
-21.1009%
300.858%
-4.4412%
23.573%
18.3392%
6.1224%
-16.3632%
-33.3978%
-23.7925%
-12.3555%
-7.0413%
26.7284%
19.3807%
170.9514%
73.6966%
8.8915%
50.8052%
-82.9829%
-54.4562%
31.998%
8.6139%
340.8491%
194.0726%
1.6382%
-53.3893%
-14.6961%
15.2129%
29.3008%
156.6213%
146.797%
48.4555%
-0.6994%
-5.9749%
-48.0739%
-41.9001%
-2.2654%
0.7431%
17.714%
3.4656%
-23.1586%
-9.2034%
-30.3225%
-33.0067%
5.8267%
-9.6852%
-34.1882%
9.0852%
-9.4666%
-1.7051%
3.3992%
-15.672%
-0.3368%
-0.808%
-2.7869%
9.9327%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.